Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?

C. Arnold Spek, JanWillem Duitman

Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Journal Issue: June
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Arnold Spek, JanWillem Duitman. Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?. Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Idiopathic pulmonary fibrosis: current challenges and future perspectives
Source: Eur Respir Rev 2013; 22: 103-105
Year: 2013

What have we learned from basic science studies on idiopathic pulmonary fibrosis?
Source: Eur Respir Rev, 28 (153) 190029; 10.1183/16000617.0029-2019
Year: 2019

Idiopathic pulmonary fibrosis: present understanding and future options
Source: Eur Respir Rev 2011; 20: 132-133
Year: 2011

A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015

Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences
Source: Eur Respir Rev 2015; 24: 420-427
Year: 2015

Idiopathic pulmonary fibrosis trials: recommendations for the jury
Source: Eur Respir J 2011; 38: 1002-1004
Year: 2011

Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies
Source: Eur Respir J, 52 (3) 1801485; 10.1183/13993003.01485-2018
Year: 2018

Idiopathic pulmonary fibrosis: recent milestones in disease management
Source: Eur Respir Rev 2012; 21: 140
Year: 2012

Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012

Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009

Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice
Source: International Congress 2015 – Treatment of IPF
Year: 2015

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018
Year: 2019

Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice
Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017
Year: 2017

Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017
Year: 2017

Imaging of idiopathic pulmonary fibrosis based on case presentations: guidelines, pitfalls and prevention of misdiagnosis
Source: Virtual Congress 2021 – Imaging grand round
Year: 2021

Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science
Source: Eur Respir J 2016; 47:1615-1617
Year: 2016

Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
Source: Eur Respir Rev 2014; 23:193-214
Year: 2014

The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF
Source: Eur Respir J 2015; 46: 883-886
Year: 2015

Idiopathic pulmonary fibrosis: classification, epidemiology, course and prognosis
Source: International Congress 2016 – Russia Session
Year: 2016